Auxano Advisors, LLC Amgen Inc Transaction History

Auxano Advisors, LLC

$368 Million
Q3 2024

A detailed history of Auxano Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Auxano Advisors, LLC holds 2,510 shares of AMGN stock, worth $739,270. This represents 0.22% of its overall portfolio holdings.

Number of Shares

2,510

Previous 2,502 0.32%

Holding current value

$739,270

Previous $781,000 3.46%

% of portfolio

0.22%

Previous 0.22%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$309.38 - $337.38 $2,475 - $2,699	8 Added 0.32%	2,510 $808,000
Q2 2024 Jul 31, 2024	BUY	$262.75 - $319.31 $10,772 - $13,091	41 Added 1.67%	2,502 $781,000
Q1 2024 May 02, 2024	BUY	$268.87 - $324.56 $537 - $649	2 Added 0.08%	2,461 $699,000
Q4 2023 Feb 05, 2024	SELL	$255.7 - $288.46 $47,815 - $53,942	-187 Reduced 7.07%	2,459 $708,000
Q3 2023 Nov 07, 2023	BUY	$218.65 - $271.46 $18,147 - $22,531	83 Added 3.24%	2,646 $711,000
Q1 2023 Apr 27, 2023	BUY	$225.79 - $275.2 $12,870 - $15,686	57 Added 2.27%	2,563 $619,000
Q4 2022 Feb 03, 2023	BUY	$229.03 - $291.01 $2,061 - $2,619	9 Added 0.36%	2,506 $658,000
Q3 2022 Nov 02, 2022	BUY	$224.46 - $253.15 $5,611 - $6,328	25 Added 1.01%	2,497 $563,000
Q2 2022 Aug 05, 2022	SELL	$230.71 - $256.74 $1,153 - $1,283	-5 Reduced 0.2%	2,472 $601,000
Q1 2022 May 06, 2022	BUY	$219.27 - $242.57 $14,471 - $16,009	66 Added 2.74%	2,477 $599,000
Q4 2021 Feb 04, 2022	BUY	$198.88 - $227.6 $137,823 - $157,726	693 Added 40.34%	2,411 $542,000
Q2 2021 Aug 06, 2021	BUY	$233.58 - $259.14 $5,839 - $6,478	25 Added 1.48%	1,718 $419,000
Q1 2021 Apr 29, 2021	BUY	$221.91 - $258.6 $4,882 - $5,689	22 Added 1.32%	1,693 $421,000
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $2,596 - $3,092	12 Added 0.72%	1,671 $384,000
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $328,166 - $402,705	1,659 New	1,659 $391,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Auxano Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Auxano Advisors, LLC with notifications on news.

Account

Auxano Advisors, LLC Amgen Inc Transaction History